Abstract: A subcutaneous implantable medical device and method (SIMD) provided. A pulse generator (PG) is configured to be positioned subcutaneously within a lateral region of a chest of a patient. The PG has a housing that includes a PG electrode. The PG has an electronics module. An elongated lead is electrically coupled to the pulse generator. The elongated lead includes a first electrode that is configured to be positioned along a first parasternal region proximate a sternum of the patient and a second electrode that is configured to be positioned at an anterior region of the patient. The first and second electrodes are coupled to be electrically common with one another. The electronics module is configured to provide electrical shocks for antiarrhythmic therapy along at least one shocking vector between the PG electrode and the first and second electrodes.
Type:
Application
Filed:
May 7, 2018
Publication date:
November 7, 2019
Applicant:
Pacesetter, Inc.
Inventors:
Xiaoyi Min, Kyungmoo Ryu, Keith Victorine, Stuart Rosenberg, Gene A. Bornzin
Abstract: Implantable cardiac stimulation devices configured to deliver more than one pacing pulse per cardiac cycle, and methods for use therewith, are described herein. A method can include delivering a first pacing pulse using a first pair of electrodes. Thereafter, between delivery of the first pacing pulse and delivery of second pacing pulse using a second (different) pair of electrodes, one or more voltage characteristics are measured at each of a plurality of different nodes within the cardiac stimulation device. A preferred pair of nodes for use during a fast discharge phase are identified based on the measured voltage characteristic(s). Switches within the implantable cardiac stimulation device are controlled so that the pair of nodes, identified as being the preferred pair of nodes that are to be used for performing the fast discharge phase, are used for performing the fast discharge phase to thereby achieve charge neutrality in an improved manner.
Abstract: Methods and devices for managing establishment of a communications link between an external instrument (EI) and an implantable medical device (IMD) are provided. The methods and devices comprise storing, in memory in at least one of the IMD or the EI an advertising schedule defining a pattern for advertisement notices. The advertisement notices are distributed un-evenly and separated by unequal advertisement intervals. The method transmits, from a transmitter in at least one of the IMD or the EI the advertisement notices. The advertisement notices are distributed as defined by the advertising schedule. The method establishes a communication session between the IMD and the EI.
Abstract: Catheter-based delivery systems for delivery and retrieval of a leadless pacemaker include features to facilitate improved manipulation of the catheter and improved capture and docking functionality of leadless pacemakers. Such functionality includes mechanisms directed to deflecting and locking a deflectable catheter, maintaining tension on a retrieval feature, protection from anti-rotation, and improved docking cap and drive gear assemblies.
Type:
Grant
Filed:
October 13, 2017
Date of Patent:
October 22, 2019
Assignee:
Pacesetter, Inc.
Inventors:
Bernhard Arnar, Bradley Knippel, Jeremiah Blue, Jennifer Heisel, Rebecca Stufft, Adam Weber
Abstract: Methods and systems are provided for discriminating rhythm patterns in cardiac activity. The method and system obtain cardiac activity data for multiple cardiac beats over a predetermined period of time. Multi-beat segments within the cardiac activity data exhibit different rhythm patterns of interest including fast and slow rhythm patterns. The method and system calculate a cardiac beats timing relation representative of intervals between the cardiac beats within a measurement window, wherein the measurement window is configured to overlap the corresponding multi-beat segment. The method and system designate the cardiac beats timing relation to have one of the rhythm patterns of interest based on a rate threshold, identifies when successive multi-beat segments exhibit rhythm patterns that transition between the fast and slow irregular rhythm patterns and records the irregular rhythm pattern transition in connection with the cardiac activity data.
Abstract: A medical tool includes a rotation mechanism that further includes a warning feature. The warning feature provides an indication when the rotation mechanism has achieved a number of rotations.
Type:
Grant
Filed:
August 18, 2017
Date of Patent:
October 15, 2019
Assignee:
Pacesetter, Inc.
Inventors:
Peter Nee, Bradley Knippel, Daniel Coyle, Jennifer Heisel, Bernhard Arnar, Brett Hillukka, Tracee Eidenschink, Thomas B. Eby, Paul Paspa, Joseph Ramon Callol, Thomas Robert Luhrs, Carl Lance Boling
Abstract: A system for implanting an implantable medical device (IMD) within a patient may include an IMD including an attachment member, and a delivery catheter including at least one tethering device having at least a portion positioned within a restrainer. The tethering device(s) is configured to removably tether to the attachment member of the IMD. The restrainer is configured to maintain the tethering device(s) in alignment along a delivery path of the delivery catheter.
Type:
Grant
Filed:
September 9, 2014
Date of Patent:
October 15, 2019
Assignee:
Pacesetter, Inc.
Inventors:
Paul Paspa, Joseph Ramon Callol, Thomas B. Eby
Abstract: The present disclosure provides systems and methods for automatically determining pace and sense configurations for an implantable cardiac device. A method of operating an implantable cardiac device includes automatically determining, during a detection phase, a pace and sense configuration for the implantable cardiac device based on a plurality of first impedance measurements. The method further includes confirming, during a confirmation phase, the pace and sense configuration based on a plurality of second impedance measurements, and operating the implantable cardiac device in accordance with the pace and sense configuration.
Abstract: A medical tool includes a rotation mechanism that further includes a warning feature. The warning feature provides an indication when the rotation mechanism has achieved a number of rotations.
Type:
Grant
Filed:
August 18, 2017
Date of Patent:
October 1, 2019
Assignee:
PACESETTER, INC.
Inventors:
Thomas B. Eby, Bradley Knippel, Daniel Coyle, Jennifer Heisel, Bernhard Arnar, Brett Hillukka, Tracee Eidenschink, Paul Paspa, Joseph Ramon Callol
Abstract: Anode foil, preferably aluminum anode foil, is etched using a process of treating the foil in an electrolyte bath composition comprising a persulfate, a halide, an oxidizing agent, and a sulfate. An etch resist can be added to the anode foil prior to etching. The anode foil and the attached etch resist can be heated prior to immersing both in an electrolyte bath composition. The anode foil is etched in the electrolyte bath composition by passing a charge through the bath, while maintaining a constant level of persulfate. The etched anode foil is suitable for use in an electrolytic capacitor.
Type:
Grant
Filed:
March 15, 2017
Date of Patent:
September 24, 2019
Assignee:
PACESETTER, INC.
Inventors:
Ralph Jason Hemphill, David R. Bowen, James Brian Smith, Timothy R. Marshall
Abstract: An implantable medical lead may include a lead body, a substrate, and an elastic deflection component. The lead body includes a proximal end configured to couple to an implantable pulse generator, a distal end opposite the proximal end, and an electrical conductor extending through the lead body. The substrate is at the distal end and supports an array of electrodes. The elastic deflection component physically and electrically connects the electrical conductor and an electrode of the array of electrodes. The elastic deflection component is configured to compensate for at least one of tension forces or compression forces transferred from the electrical conductor to the electrode of the array of electrodes.
Abstract: The present disclosure provides systems and methods for implanting an implantable cardiac monitor. An injection system includes an implantable cardiac monitor (ICM), a plunger, a plunger handle coupled the plunger, and an injector housing. The injector housing includes a tube extending from a first end of the injector housing to a second end of the injector housing, the tube configured to receive the ICM and the plunger, and at least one leaflet formed at the second end of the injector housing, the at least one leaflet configured to rotate outward when a user operates the plunger handle to push the ICM through the injector housing second end via the plunger.
Type:
Grant
Filed:
February 21, 2017
Date of Patent:
September 17, 2019
Assignee:
PACESETTER, INC.
Inventors:
Abigail Valbuena, Gene A. Bornzin, Zoltan Somogyi, Didier Theret
Abstract: A medical tool includes a rotation mechanism that further includes a warning feature. The warning feature provides an indication when the rotation mechanism has achieved a number of rotations.
Type:
Grant
Filed:
August 18, 2017
Date of Patent:
September 10, 2019
Assignee:
PACESETTER, INC.
Inventors:
Thomas B. Eby, Bradley Knippel, Daniel Coyle, Jennifer Heisel, Bernhard Arnar, Brett Hillukka, Tracee Eidenschink, Paul Paspa, Joseph Ramon Callof
Abstract: Disclosed herein is a system for delivering a leadless pacemaker having a housing with a proximal end. The system includes a guide catheter. The guide catheter includes a catheter shaft and a negative pressure attachment feature. The catheter shaft includes a distal end and a proximal end opposite the distal end. The negative pressure attachment feature is located at the distal end of the catheter shaft and configured to selectively negative pressure adhere with the housing of the leadless pacemaker.
Type:
Grant
Filed:
April 26, 2017
Date of Patent:
September 3, 2019
Assignee:
PACESETTER, INC.
Inventors:
Thomas B. Eby, Arundhati Kabe, Paul Paspa
Abstract: An implantable medical device is disclosed herein and can be in the form of an implantable medical lead or a leadless pulse generator. The implantable medical device includes a body, at least one electrode and a tube-cut helical fixation anchor. The body includes a distal end and a proximal end opposite the distal end. The at least one electrode is supported on the body. The tube-cut helical fixation anchor distally extends from the distal end. The tube-cut helical fixation anchor may be fixed or extendable/retractable relative to the distal end. The tube-cut helical fixation anchor may be a result of a manufacturing process comprising cutting the tube-cut helical fixation anchor from a thin-walled tubular body.
Type:
Grant
Filed:
September 11, 2015
Date of Patent:
August 27, 2019
Assignee:
Pacesetter, Inc.
Inventors:
Ivan Ma, Bruce Weir, Matthew G. Fishler, Ott Khouengboua
Abstract: A system and method for controlling non-paresthesia stimulation of neural tissue of a patient. The method delivers a non-paresthesia stimulation waveform, senses sensory action potential (SAP) signals from the neural tissue of interest and analyzes the SAP signals to obtain SAP activity data for at least one of an SAP C-fiber component or an SAP A-delta fiber component. The method determines whether the SAP activity data satisfies a criteria of interest and adjusts at least one of the therapy parameters to change the non-paresthesia stimulation waveform when the SAP activity data does not satisfy the criteria of interest.
Type:
Application
Filed:
April 30, 2019
Publication date:
August 22, 2019
Applicant:
PACESETTER, INC.
Inventors:
Wenbo Hou, Melanie Goodman Keiser, Xiaoyi Min, Bruce A. Morley
Abstract: The present disclosure generally relates to extraforaminal electrical stimulation systems and leads for electrical stimulation of the dorsal root and dorsal root ganglion (DRG), minimally invasive implantation methods therefore, and related methods of providing extraforaminal electrical stimulation of the dorsal root and DRG for the treatment of a medical condition. In accordance with certain aspects, the extraforaminal electrical stimulation leads and methods are particularly suited for stimulation of dorsal roots and DRG of the cervical and thoracic spine.
Type:
Grant
Filed:
December 21, 2016
Date of Patent:
August 13, 2019
Assignee:
PACESETTER, INC.
Inventors:
Alexander Kent, William Cusack, Xiaoyi Min, Gene A. Bornzin
Abstract: A renal denervation feedback method is described that performs a baseline measurement of renal nerve plexus electrical activity at a renal vessel; denervates at least some tissue proximate the renal vessel after performing the baseline measurement; performs a post-denervation measurement of renal nerve plexus electrical activity at the renal vessel, after the denervating; and assesses denervation of the renal vessel based on a comparison of the baseline measurement and the post-denervation measurement of renal nerve plexus electrical activity at the renal vessel.
Type:
Grant
Filed:
September 27, 2017
Date of Patent:
August 13, 2019
Assignee:
Pacesetter, Inc.
Inventors:
Eric S. Fain, Martin Cholette, Gary R. Dulak, Gene A. Bornzin, John W. Poore
Abstract: A method of fabricating a battery electrode includes forming a mixture including an electrode material and a binder; forming an electrode blank from the mixture; heating the electrode blank at a predetermined temperature for a predetermined time to form an annealed electrode blank; and laminating the annealed electrode blank to a current collector. The current collector may include a conductive carbon coating. In such event, the method may further include heating the current collector at a selected temperature for a selected time prior to laminating the annealed electrode blank to the current collector.
Abstract: An exemplary method for optimizing pacing configuration includes providing distances between electrodes of a series of three or more ventricular electrodes associated with a ventricle; selecting a ventricular electrode from the series; delivering energy to the ventricle via the selected ventricular electrode, the energy sufficient to cause an evoked response; acquiring signals of cardiac electrical activity associated with the evoked response via non-selected ventricular electrodes of the series; based on signals of cardiac electrical activity acquired via the non-selected ventricular electrodes and the distances, determining conduction velocities; based on the conduction velocities, deciding if the selected ventricular electrode is an optimal electrode for delivery of a cardiac pacing therapy; and, if the selected ventricular electrode comprises an optimal electrode for delivery of the cardiac pacing therapy, calling for delivery of the cardiac pacing therapy using the selected ventricular electrode.